AOA is dedicated to early diagnosis and treatment of cancer. Our diagnostic and therapeutic pipelines focus on development of novel targets.
AOA is committed to developing tools to help clinicians diagnose cancers early, when it matters most:
AOA has a pipeline of novel therapeutic targets that show tremendous potential in the pre-clinical stages:
Our goal is to work closely with scientific innovators to bring their findings to market and make them widely available to impact clinical practice today and improve standard of care.